CYCCYCLOPHARM LIMITED
Announcement history available from 1 August 2025
Fromto
| Date / Time | Title | Type | MS | Report Codes | |
|---|---|---|---|---|---|
| 29 July 2026, 18:31 | New US Lung Imaging Guidelines Name Technegas as Preferred A | Company Update | MS | 11001 | |
| 28 July 2026, 18:50 | ausbiz TV Presentation | Presentations | — | 03026 | |
| 15 July 2026, 18:29 | Immediate 11-Site Technegas Rollout at University Hospitals | Company Update | MS | 11001 | |
| 7 July 2026, 01:05 | Notification of cessation of securities - CYC | Other | — | 06027 | |
| 2 July 2026, 20:11 | CYC First-Half 2026 Update | Periodic Reports | MS | 03014 | |
| 26 June 2026, 03:19 | Change in substantial holding | Substantial Holders | — | 02002 | |
| 9 May 2026, 00:32 | Final Director's Interest Notice - KB | Director Interests | — | 02010 | |
| 9 May 2026, 00:31 | Final Director's Interest Notice - DH | Director Interests | — | 02010 | |
| 9 May 2026, 00:28 | Results of Meeting | Meetings & Governance | — | 08003 | |
| 8 May 2026, 20:14 | CYC 2026 AGM Presentation | Presentations | — | 02006, 03026, 12001, 15002 | |
| 8 May 2026, 20:12 | Managing Director's Address to Shareholders | Company Administration | — | 12001, 15002 | |
| 8 May 2026, 20:11 | Chair's Address to Shareholders | Company Administration | — | 12001, 12017, 15002 | |
| 4 May 2026, 19:51 | Appointment of Non-Executive Director and Incoming Chair | Meetings & Governance | — | 08006, 12001, 12017 | |
| 4 May 2026, 19:47 | Initial Director's Interest Notice - DC | Director Interests | — | 02008 | |
| 22 Apr 2026, 19:03 | Change in substantial holding | Substantial Holders | — | 02002 | |
| 20 Apr 2026, 23:09 | Cleansing Notice | Securities Administration | — | 06018 | |
| 20 Apr 2026, 22:57 | Application for quotation of securities - CYC | Other | — | 06020 | |
| 20 Apr 2026, 20:42 | AGM - Supplementary Disclosure | Meetings & Governance | — | 06009, 08006 | |
| 10 Apr 2026, 21:18 | Notice of Annual General Meeting/Proxy Form | Meetings & Governance | — | 08001, 08004 | |
| 7 Apr 2026, 20:26 | Final Director's Interest Notice - JW | Director Interests | — | 02010 | |
| 7 Apr 2026, 20:24 | Resignation of Non-Executive Director John Wigglesworth | Company Administration | — | 12001 | |
| 31 Mar 2026, 19:42 | USA Technegas Expansion Update | Company Update | MS | 11001 | |
| 28 Mar 2026, 03:56 | Appendix 4G and Corporate Governance Statement | Company Administration | — | 03024, 03025 | |
| 28 Mar 2026, 03:53 | Annual Report to shareholders | Financial Results | — | 03001, 03002, 03011, 03012, 03013, 03020 | |
| 24 Mar 2026, 19:28 | CYC Secures Multi-Site Agreement with Northwestern Medicine | Company Update | MS | 11001 | |
| 23 Mar 2026, 20:16 | CYC Signs Enterprise Agreement with UPHS | Company Update | MS | 11001 | |
| 13 Mar 2026, 00:19 | Change of Director's Interest Notice - KB | Director Interests | — | 02009 | |
| 13 Mar 2026, 00:19 | Change of Director's Interest Notice - JW | Director Interests | — | 02009 | |
| 13 Mar 2026, 00:18 | Change of Director's Interest Notice - DA | Director Interests | — | 02009 | |
| 13 Mar 2026, 00:17 | Change of Director's Interest Notice - JM | Director Interests | — | 02009 | |
| 13 Mar 2026, 00:15 | Change of Director's Interest Notice - DH | Director Interests | — | 02009 | |
| 12 Mar 2026, 21:10 | Application for quotation of securities - CYC | Other | — | 06020 | |
| 10 Mar 2026, 22:21 | Date of Annual General Meeting | Meetings & Governance | — | 08006, 12008 | |
| 9 Mar 2026, 22:52 | Response to ASX Aware Letter | ASX Query | — | 17003 | |
| 9 Mar 2026, 22:35 | Results of CYC Share Purchase Plan | Capital Raising | — | 06017 | |
| 26 Feb 2026, 04:20 | Update - Proposed issue of securities - CYC | Securities Administration | — | 06013 | |
| 26 Feb 2026, 04:12 | Preliminary Final Report | Financial Results | MS | 03003 | |
| 26 Feb 2026, 04:06 | Chairman David Heaney to Retire at 2026 AGM | Other | — | 12017 | |
| 19 Feb 2026, 23:31 | Technegas US Footprint Expanding Across Four Regions | Company Update | MS | 11001 | |
| 18 Feb 2026, 23:32 | Technegas Approved at the US National Institutes of Health | Company Update | MS | 11001 | |
| 14 Feb 2026, 03:28 | Becoming a substantial holder | Substantial Holders | — | 02001 | |
| 12 Feb 2026, 20:10 | Share Purchase Plan Offer Booklet | Capital Raising | — | 06017, 16002 | |
| 11 Feb 2026, 20:18 | Cleansing Notice | Capital Raising | — | 06003, 06018 | |
| 11 Feb 2026, 20:14 | Application for quotation of securities - CYC | Other | — | 06020 | |
| 4 Feb 2026, 20:41 | Proposed issue of securities - CYC | Securities Administration | — | 06013 | |
| 4 Feb 2026, 20:41 | Cyclopharm Capital Raising Investor Presentation | Presentations | MS | 03026 | |
| 4 Feb 2026, 20:40 | Cyclopharm Successfully Completes A$14 million Placement | Capital Raising | MS | 06003, 06017, 09014 | |
| 2 Feb 2026, 20:39 | CYC Unaudited Trading Update - Preliminary FY2025 Results | Other | MS | 03028 | |
| 2 Feb 2026, 20:07 | Trading Halt | Trading Halt / Suspension | MS | 09007 | |
| 29 Jan 2026, 19:19 | COPD Study Leveraging Technegas and AI-Driven Lung Analysis | Company Update | MS | 11001 |
1–50 of 63
1 / 2